Weed’s Wild Ride: What Drug Class Does This Green Goodness Actually Belong To?
Cannabis pharmacology challenges clinicians due to its complex effects spanning depressant, stimulant, and hallucinogenic properties. Understanding cannabis's drug classification is essential for safe clinical dosing and patient counseling. This article…
Alabama’s First Cannabis Dispensary Launches in Montgomery This Year
The Alabama cannabis dispensary opening 2026 in Montgomery marks a pivotal moment for patient access to regulated cannabis products. This launch introduces standardized, tested cannabis options for Alabama patients. Clinicians now have an opportunity to…
Ontario Considers Earlier Opening Hours for Legal Cannabis Stores
Ontario cannabis policy updates are being considered to allow legal cannabis stores to open earlier. This change aims to improve patient access, especially for those with conflicting work schedules. The focus is on enhancing regulated dispensary…
Constitutional Issues in Cannabis Law: Rhode Island Analysis
Constitutional cannabis challenges directly impact patient access to medical cannabis and clinical practice frameworks. Legal uncertainties can disrupt treatment protocols and require clinicians to adapt. Understanding these challenges is essential for…
$80M Cannabis Bust Leads to $50K Fine for Leamington Company
The 80M cannabis seizure regulatory impact highlights enforcement actions affecting medical cannabis supply chains. A $50K fine was issued against a Leamington company for compliance violations. These regulatory measures emphasize the importance of…
Week in Weed – April 11, 2026 – StratCann Highlights
This Week in Weed covers cannabis clinical relevance April 11 2026 with emerging findings and policy updates. Clinicians should review these developments carefully. The insights help inform cannabis medicine and clinical practice.
New Cannabis Models Under the Microscope: Less Illegal Sales, But at What Price?
This article examines new cannabis models under microscope and their effect on illegal sales reduction. Clinicians should monitor these cannabis policy developments closely. Emerging findings highlight important clinical practice updates.
New York Licenses Five New Medical Marijuana Companies
The new york medical marijuana program expansion includes licensing five new companies to enhance patient access. This growth aims to improve product availability and competitive pricing. Patients and clinicians alike benefit from increased options…
Whether You’re New to Medical Cannabis or Continuing Your Patient Journey
The medical cannabis patient journey requires informed decisions and ongoing support. Whether you're new or continuing, understanding this journey is essential. This article highlights key aspects of the medical cannabis patient journey.
Clinics Handing Out Medicinal Cannabis for Anxiety and Depression Despite ‘No Evidence’ It Works
Clinics handing out medicinal cannabis anxiety treatments are increasing despite limited evidence of effectiveness. This trend raises important questions for clinicians and patients alike. Monitoring emerging research is essential for informed clinical…